Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natalie S Callander

Showing results (21-30 of 95) with videos related to

Pageof 10
Sort By:
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|July 9, 2016
Utilization and evaluation of noncore chemotherapy regimens within an academic medical centerJason R Jared, Mary S Mably, Rory Makielski, et al.
Leukemia & Lymphoma|January 27, 2021
Targeted treatment of multiple myeloma with a radioiodinated small molecule radiopharmaceuticalAnkita Shahi, Gerald E Weiss, Saswati Bhattacharya, et al.
British Journal of Haematology|May 16, 2012
Macrophages and mesenchymal stromal cells support survival and proliferation of multiple myeloma cellsJaehyup Kim, Ryan A Denu, Bridget A Dollar, et al.
Clinical Lymphoma & Myeloma|July 25, 2008
Thalidomide maintenance following high-dose melphalan with autologous stem cell support in myelomaJulie E Chang, Mark B Juckett, Natalie S Callander, et al.
Blood|November 15, 2003
IL-3 expression by myeloma cells increases both osteoclast formation and growth of myeloma cellsJun Won Lee, Ho Yeon Chung, Lori A Ehrlich, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 13, 2018
Granulocyte colony-stimulating factor utilization postautologous hematopoietic stem cell transplant in multiple myeloma patients: Does one size fit all?Emily R Jackson, Jason R Jared, Jennifer K Piccolo, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 4, 2005
Denileukin diftitox for the treatment of steroid-resistant acute graft-versus-host diseasePaul J Shaughnessy, Carlos Bachier, Michael Grimley, et al.
Journal of Pain and Symptom Management|April 18, 2026
A Behavioral Intervention to Improve Symptoms After Hematopoietic Cell TransplantationElizabeth S Ver Hoeve, Beyann Alzoubi, Meredith E Rumble, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 6, 2022
Optimizing Thromboembolism Prophylaxis for the Contemporary Age of Multiple MyelomaMuhamed Baljevic, Douglas W Sborov, Ming Y Lim, et al.
Blood|April 7, 2025
Optimal MRD-based end point to support response-adapted treatment cessation in newly diagnosed multiple myelomaSmith Giri, Binod Dhakal, Natalie S Callander, et al.
Pageof 10

Showing results (21-30 of 95) with videos related to

Sort By:
Pageof 10
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|July 9, 2016
Utilization and evaluation of noncore chemotherapy regimens within an academic medical centerJason R Jared, Mary S Mably, Rory Makielski, et al.
Leukemia & Lymphoma|January 27, 2021
Targeted treatment of multiple myeloma with a radioiodinated small molecule radiopharmaceuticalAnkita Shahi, Gerald E Weiss, Saswati Bhattacharya, et al.
British Journal of Haematology|May 16, 2012
Macrophages and mesenchymal stromal cells support survival and proliferation of multiple myeloma cellsJaehyup Kim, Ryan A Denu, Bridget A Dollar, et al.
Clinical Lymphoma & Myeloma|July 25, 2008
Thalidomide maintenance following high-dose melphalan with autologous stem cell support in myelomaJulie E Chang, Mark B Juckett, Natalie S Callander, et al.
Blood|November 15, 2003
IL-3 expression by myeloma cells increases both osteoclast formation and growth of myeloma cellsJun Won Lee, Ho Yeon Chung, Lori A Ehrlich, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 13, 2018
Granulocyte colony-stimulating factor utilization postautologous hematopoietic stem cell transplant in multiple myeloma patients: Does one size fit all?Emily R Jackson, Jason R Jared, Jennifer K Piccolo, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 4, 2005
Denileukin diftitox for the treatment of steroid-resistant acute graft-versus-host diseasePaul J Shaughnessy, Carlos Bachier, Michael Grimley, et al.
Journal of Pain and Symptom Management|April 18, 2026
A Behavioral Intervention to Improve Symptoms After Hematopoietic Cell TransplantationElizabeth S Ver Hoeve, Beyann Alzoubi, Meredith E Rumble, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 6, 2022
Optimizing Thromboembolism Prophylaxis for the Contemporary Age of Multiple MyelomaMuhamed Baljevic, Douglas W Sborov, Ming Y Lim, et al.
Blood|April 7, 2025
Optimal MRD-based end point to support response-adapted treatment cessation in newly diagnosed multiple myelomaSmith Giri, Binod Dhakal, Natalie S Callander, et al.
Pageof 10